Cintas (CTAS) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
9 Jul, 2026Executive summary
Fiscal Q1 2025 revenue reached $2.5 billion, up 6.8% year-over-year, with organic growth at 8.0% after adjusting for acquisitions, FX, and one less workday, driven by new business, product penetration, and price increases.
Net income increased 17.4% to $452 million, and diluted EPS rose 18.3% to $1.10, reflecting strong operational performance, margin expansion, and a recent four-for-one stock split.
All business divisions contributed to growth, with strong demand across healthcare, hospitality, education, and government verticals.
Operational excellence, technology investments, and supply chain initiatives drove margin expansion and efficiency.
Cash flow from operations grew 38.5% to $466.7 million; free cash flow reached $373.8 million.
Financial highlights
Gross margin rose 9.7% year-over-year to $1.25 billion, reaching a record 50.1% of revenue.
Operating income was $561 million (22.4% of revenue), up 12.1% year-over-year.
Uniform rental and facility services revenue grew 5.9% to $1.93 billion; First Aid and Safety Services revenue increased 12.2% to $292.6 million.
Net income was $452 million, up from $385.1 million last year.
Dividends paid totaled $157.9 million, with a 15.6% increase marking 41 consecutive years of growth.
Outlook and guidance
Fiscal 2025 revenue guidance raised to $10.22–$10.32 billion (6.5%–7.5% growth); organic growth expected at 7.0%–8.1%.
Diluted EPS guidance increased to $4.17–$4.25 (10.0%–12.1% growth).
Effective tax rate expected at 20.4% for fiscal 2025.
Guidance assumes no future acquisitions, constant FX, and no additional share buybacks.
Management expects continued sufficient liquidity and access to $2.0 billion in revolving credit.
Latest events from Cintas
- Record revenue and margin growth in 2026; strong 2027 outlook with continued investment.CTAS
Q4 202615 Jul 2026 - Revenue and net income surged, margins expanded, and guidance was raised for the full year.CTAS
Q2 20259 Jul 2026 - Q1 revenue and net income rose 8.7%, with raised guidance and strong share repurchases.CTAS
Q1 20269 Jul 2026 - Q3 revenue and EPS surged, driving higher guidance and robust margin expansion.CTAS
Q3 20258 Jul 2026 - Record growth, margin expansion, and a four-for-one stock split set the stage for 2025.CTAS
Q4 20248 Jul 2026 - Record revenue, margin highs, and raised guidance driven by broad-based growth and strong retention.CTAS
Q2 20268 Jul 2026 - Q3 revenue up 8.9%, record margins, guidance raised, $5.5B UniFirst deal announced.CTAS
Q3 20267 Apr 2026 - $5.5B merger delivers $375M synergies, $310/share for UniFirst, closing in H2 2026.CTAS
M&A announcement11 Mar 2026 - Directors and key proposals were voted on, with all board and management recommendations approved.CTAS
AGM 202418 Jan 2026